175 related articles for article (PubMed ID: 3145248)
1. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
[TBL] [Abstract][Full Text] [Related]
5. Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow).
Shields JG; Smith SH; Strobel S; Levinsky RJ; Defrance T; De Vries J; Banchereau J; Callard RE
Eur J Immunol; 1988 Feb; 18(2):255-9. PubMed ID: 2832180
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
[TBL] [Abstract][Full Text] [Related]
9. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
Arnold A; Lipkowitz S; Suthanthiran M; Novogrodsky A; Stenzel KH
J Immunol; 1985 Jun; 134(6):3876-81. PubMed ID: 2985701
[TBL] [Abstract][Full Text] [Related]
10. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
11. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
Ling NR; Lowe JA
Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line.
Yoshizaki K; Nakagawa T; Fukunaga K; Tseng LT; Yamamura Y; Kishimoto T
J Immunol; 1984 Jun; 132(6):2948-54. PubMed ID: 6202767
[TBL] [Abstract][Full Text] [Related]
13. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
14. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
17. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors.
Tadmori W; Lee HK; Clark SC; Choi YS
J Immunol; 1989 Feb; 142(3):826-32. PubMed ID: 2783602
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
Tseng CT; Springgate CF; Tadmori W; Choi YS
J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
20. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]